Covis Pharma

FDA forces unproven premature birth drug Makena off market
FDA forces unproven premature birth drug Makena off market
The Hill
Makena
premature birth
Covis Pharma
FDA
Flag link:
FDA decision on preterm birth drug’s withdrawal nears, putting spotlight on patients, agency
FDA decision on preterm birth drug’s withdrawal nears, putting spotlight on patients, agency
BioPharma Dive
FDA
Makena
preterm birth
Covis Pharma
Flag link:
Adcomm again votes to pull controversial pre-term birth drug from the market
Adcomm again votes to pull controversial pre-term birth drug from the market
Endpoints
FDA
Covis Pharma
Makena
preterm birth
Flag link:
FDA opens case to withdraw controversial drug for preterm births
FDA opens case to withdraw controversial drug for preterm births
BioPharma Dive
FDA
Makena
Covis Pharma
preterm birth
Flag link:
FDA Review: Phanes, Pfizer, GSK and More
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
FDA
Phanes
Pfizer
GSK
Regeneron
Eagle Pharmaceuticals
Galactin Therapeutics
BridgeBio
Gilead Sciences
Covis Pharma
scPharmaceuticals
XACT Robotics
BioMind Labs
Flag link:
Covis' controversial Makena gets FDA hearing date in bid to stay on the market
Covis' controversial Makena gets FDA hearing date in bid to stay on the market
Fierce Pharma
Makena
Covis Pharma
FDA
preterm birth
Flag link:
FDA plots multi-day hearing to review 'dangling' accelerated approval that drugmaker refuses to pull
FDA plots multi-day hearing to review 'dangling' accelerated approval that drugmaker refuses to pull
Endpoints
FDA
accelerated approvals
Covis Pharma
Flag link:
FDA lawyer digs in her heels as Makena accelerated approval withdrawal saga drags on
FDA lawyer digs in her heels as Makena accelerated approval withdrawal saga drags on
Endpoints
Covis Pharma
Makena
FDA
preterm birth
Flag link:
Premature birth drug saga drags on as Covis questions fairness of FDA hearing
Premature birth drug saga drags on as Covis questions fairness of FDA hearing
Endpoints
Makena
Covis Pharma
FDA
premature birth
Flag link:
AstraZeneca Purges Two Respiratory Medicines in Big Day for Covis
AstraZeneca Purges Two Respiratory Medicines in Big Day for Covis
BioSpace
AstraZeneca
COPD
Covis Pharma
Respiratory
Flag link:
Covis granted FDA hearing in latest twist over controversial premature-birth med Makena
Covis granted FDA hearing in latest twist over controversial premature-birth med Makena
Fierce Pharma
Covis Pharma
Makena
preterm birth
FDA
Flag link:
FDA puts its foot down on Makena: New meta-analysis does not change call to pull the drug
FDA puts its foot down on Makena: New meta-analysis does not change call to pull the drug
Endpoints
Makena
FDA
premature birth
Covis Pharma
Flag link:
AstraZeneca divests asthma and rhinitis drug rights to Covis Pharma
AstraZeneca divests asthma and rhinitis drug rights to Covis Pharma
Pharmaceutical Business Review
AstraZeneca
Covis Pharma
asthma
Flag link:
AstraZeneca Unloads Three Asthma and Rhinitis Drugs to Covis Pharma for $350 Million
AstraZeneca Unloads Three Asthma and Rhinitis Drugs to Covis Pharma for $350 Million
BioSpace
AstraZeneca
asthma
rhinitis
Covis Pharma
Alvesco
Omnaris
Zetonna
Flag link:
Sunovion divests asthma, allergy tech to Covis Pharma
Sunovion divests asthma, allergy tech to Covis Pharma
Drug Delivery Business News
Sunovion
asthma
Covis Pharma
Alvesco
Omnaris
Flag link: